Quantifying Skin Cancer Risk Following Allogeneic Haematopoietic Cell Transplant in Queensland, Australia

Overview

Journal Bone Marrow Transplant

Specialty General Surgery

Date 2023 Oct 27

PMID 37891378

Authors

Philip Wong

David C Whiteman

Catherine M Olsen

Yin Yuan

Jason Butler

Cameron Curley

Simon Durrant

Andrea Henden

James Morton

Elango Subramoniapillai

Caroline Stewart

Siok-Keen Tey

Glen A Kennedy

Ashleigh P Scott

Affiliations

Soon will be listed here.

References

Scott J, Brough K, Grigoryan K, Muzic J, Kim G, Conic R . Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants. JAMA Dermatol. 2020; 156(6):631-639. PMC: 7142796. DOI: 10.1001/jamadermatol.2020.0559. View

Curtis R, Metayer C, Rizzo J, Socie G, Sobocinski K, Flowers M . Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood. 2005; 105(10):3802-11. PMC: 1895092. DOI: 10.1182/blood-2004-09-3411. View

Rizzo J, Curtis R, Socie G, Sobocinski K, Gilbert E, Landgren O . Solid cancers after allogeneic hematopoietic cell transplantation. Blood. 2008; 113(5):1175-83. PMC: 2635083. DOI: 10.1182/blood-2008-05-158782. View

Wu P, Stern R, Huang V, Liu K, Chen C, Tzachanis D . Reduced-Intensity Conditioning Regimens, Prior Chronic Lymphocytic Leukemia, and Graft-Versus-Host Disease Are Associated with Higher Rates of Skin Cancer after Allogeneic Hematopoietic Stem Cell Transplantation. J Invest Dermatol. 2018; 139(3):591-599. DOI: 10.1016/j.jid.2018.08.025. View

DePry J, Vyas R, Lazarus H, Caimi P, Gerstenblith M, Bordeaux J . Cutaneous Malignant Neoplasms in Hematopoietic Cell Transplant Recipients: A Systematic Review. JAMA Dermatol. 2015; 151(7):775-82. DOI: 10.1001/jamadermatol.2015.121. View

Herr M, Curtis R, Tucker M, Tecca H, Engels E, Cahoon E . Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation. J Am Acad Dermatol. 2019; 83(3):762-772. PMC: 7206613. DOI: 10.1016/j.jaad.2019.10.034. View

Wojenski D, Bartoo G, Merten J, Dierkhising R, Barajas M, El-Azhary R . Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients. Transpl Infect Dis. 2015; 17(2):250-8. DOI: 10.1111/tid.12367. View

Whiteman D, Thompson B, Thrift A, Hughes M, Muranushi C, Neale R . A Model to Predict the Risk of Keratinocyte Carcinomas. J Invest Dermatol. 2016; 136(6):1247-1254. DOI: 10.1016/j.jid.2016.02.008. View

Pandeya N, Olsen C, Whiteman D . The incidence and multiplicity rates of keratinocyte cancers in Australia. Med J Aust. 2017; 207(8):339-343. DOI: 10.5694/mja17.00284. View

10.

Olsen C, Green A, Neale R, Webb P, Cicero R, Jackman L . Cohort profile: the QSkin Sun and Health Study. Int J Epidemiol. 2012; 41(4):929-929i. DOI: 10.1093/ije/dys107. View

11.

Allen N, Martin A, Snaidr V, Eggins R, Chong A, Fernandez-Penas P . Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients. N Engl J Med. 2023; 388(9):804-812. DOI: 10.1056/NEJMoa2203086. View

12.

Biswas N, Deen J, Teare H, Robertson I . Bone marrow transplant recipients and their compliance with sun-protection measures in Queensland, Australia. J Dermatol. 2020; 47(4):430-434. DOI: 10.1111/1346-8138.15262. View